Table 1.

The distributions of Kv-associated single nucleotide polymorphisms (SNPs) in 296 epileptic patients and 299 healthy controls.

Gene	SNP ID	Model	Cases (%)	Controls (%)	OR (95% CI)	p-Value *
KCNA1	rs2227910	CC/GC/GG	41.1/40.4/18.5	38.6/45.0/16.4	_	0.52
		CC/(GC + GG)	41.1/58.9	38.6/61.4	0.90 (0.65−1.25)	0.53
		(CC + GC)/GG	81.5/18.5	83.6/16.4	1.15 (0.75−1.76)	0.51
	rs112561866	GA	0.0	0.3	_	0.24
	rs7974459	CC/TC/TT	40.5/43.7/15.8	39.6/41.0/19.4	1.04 (0.72−1.50)	0.54
		CC/(TC + TT)	40.5/59.5	39.6/60.4	0.97 (0.69−1.35)	0.84
		(CC + TC)/TT	84.2/15.8	80.7/19.3	0.79 (0.51−1.21)	0.28
KCNA2	rs3887820	CC/CA/AA	79.8/18.5/1.7	82.9/15.4/1.7	_	0.6
		CC/(CA + AA)	79.8/20.2	82.9/17.1	1.23 (0.81−1.87)	0.33
		(CC + CA)/AA	98.3/1.7	98.3/1.7	1.00 (0.29−3.50)	1
KCNV2	rs7029012	GG/GC/CC	37.7/47.4/14.9	37/47.5/15.5	0.94 (0.66−1.35)	0.98
		GG/(GC + CC)	37.7/62.3	37/63	1.02(0.73−1.43)	0.91
		(GG + GC)/CC	85.1/14.9	84.5/15.5	1.04(0.66−1.63)	0.87
	rs10967705	GG/CG/CC	34.4/50.3/15.3	35.5/49.1/15.4	_	0.95
		GG/(CG + CC)	34.3/65.7	35.5/64.5	1.05 (0.75−1.47)	0.78
		(GG + CG)/CC	84.7/15.3	84.6/15.4	0.99 (0.64−1.55)	0.98
	rs10967728	GG/GC/CC	31.0/48.3/20.7	27.8/49.6/22.6	_	0.67
		GG/(GC + CC)	31.0/69.0	27.8/72.2	0.85 (0.60−1.22)	0.39
		(GG + GC)/CC	79.3/20.7	77.4/22.6	0.89 (0.60−1.33)	0.58

* Chi-Square Test with p-value < 0.05 is considered significant. OR: odds ratio; CI: confidence interval.